Show simple item record

dc.contributor.authorOkay, Müfide
dc.contributor.authorÇetik, Sıla
dc.contributor.authorHaznedaroğlu, İbrahim C.
dc.date.accessioned2021-06-03T05:19:59Z
dc.date.available2021-06-03T05:19:59Z
dc.date.issued2019
dc.identifier.issn1300-7777
dc.identifier.urihttp://dx.doi.org/10.4274/tjh.galenos.2019.2019.0113
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682773/
dc.identifier.urihttp://hdl.handle.net/11655/23957
dc.language.isoen
dc.relation.isversionof10.4274/tjh.galenos.2019.2019.0113
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleTumor Lysis Syndrome Due To Targeting Of Hepatocellular Carcinoma Associated With Chronic Myelomonocytic Leukemia
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalTurkish Journal Of Hematology
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume36
dc.identifier.issue3
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 United States
Except where otherwise noted, this item's license is described as Attribution 4.0 United States